Skip to main content
. 2017 Nov 27;6(11):396. doi: 10.1038/s41389-017-0002-x

Fig. 4.

Fig. 4

a BCK4 cells were placed in phenol red free media with steroid depleted serum 24 h prior to treatment with vehicle (EtOH), estradiol (E2), fulvestrant (ICI), imatinib mesylate (Imat) or combined treatments as specified. Proliferation was measured using the IncuCyte live cell imaging system. Fold change was calculated vs. time zero. b MDA-MB-134VI (MM134) or c SUM44PE (SUM44) cells were plated as specified above for 24 h prior to treatment with vehicle (EtOH), estradiol (E2), imatinib mesylate (Imat) or the combination of E2+Imat as specified. Proliferation was measured using the IncuCyte live cell imaging system for the times specified. Error bars show SEM. Asterisk indicates p < 0.0001 vs. vehicle control using two way ANOVA